Showing results (221-230 of 251) with videos related to
Sort By:
Pageof 26
The Lancet. Public Health|January 4, 2024
Racial and ethnic disparities in diagnosis and treatment outcomes among US-born people diagnosed with tuberculosis, 2003-19: an analysis of national surveillance dataMathilda Regan, Yunfei Li, Nicole A Swartwood, et al.American Journal of Respiratory and Critical Care Medicine|October 19, 2019
Comparative Modeling of Tuberculosis Epidemiology and Policy Outcomes in CaliforniaNicolas A Menzies, Andrea Parriott, Sourya Shrestha, et al.BMC Public Health|September 6, 2020
Mathematical modeling study of school-based chlamydia screening: potential impact on chlamydia prevalence in intervention schools and surrounding communitiesMinttu M Rönn, Richard Dunville, Li Yan Wang, et al.Journal of Clinical Medicine|March 25, 2022
Altered Circulating microRNAs in Patients with Diabetic Neuropathy and Corneal Nerve Loss: A Pilot StudyAdnan Khan, Jennifer Pasquier, Vimal Ramachandran, et al.PLOS Global Public Health|March 24, 2023
Quality of care for postpartum hemorrhage: A direct observation study in referral hospitals in KenyaEmma Clarke-Deelder, Kennedy Opondo, Emmaculate Achieng, et al.The Lancet. Global Health|August 16, 2024
Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling studyAna van Lieshout Titan, Fayette Klaassen, Daniele Maria Pelissari, et al.The Lancet. Global Health|November 19, 2021
Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelaeNicolas A Menzies, Matthew Quaife, Brian W Allwood, et al.Plos Medicine|January 24, 2023
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling studyAllison Portnoy, Rebecca A Clark, Matthew Quaife, et al.The Lancet. Global Health|March 16, 2023
The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling studyRebecca A Clark, Christinah Mukandavire, Allison Portnoy, et al.Vaccines|April 27, 2024
The Full Value of Vaccine Assessments Concept-Current Opportunities and RecommendationsRichard G White, Nicolas A Menzies, Allison Portnoy, et al.Pageof 26